Presentation Title

Adequacy of Treatments in the Case of the Melanoma of the Skin Controlling for Age and Stage

Speaker Credentials

MPH

College

Dr. Kiran C. Patel College of Osteopathic Medicine, DO

Location

Signature Grand, Davie, Florida, USA

Format

Poster

Start Date

25-4-2008 12:00 AM

End Date

25-4-2008 12:00 AM

Abstract

Objectives. Is surgery+adjuvant therapy a better treatment than surgery alone in the case of localized melanoma of the skin? Background. Melanoma of the skin is a cancer that begins in the melanocytes. The cells keep making melanin which often gives the tumor brown or black color. People with darker skin may have lower incidence of the disease, but may develop melanoma as well as people with white skin. Methods. We studied 18,550 individuals diagnosed for the first time with melanoma of the skin in the State of Florida from January 1st 1994 to December 31st 2002. The study design was a cross-sectional, with incident cases over the study period. We used the relative risk as a measure of association. The stratified Mantel-Haenszel methodology was used to assess confounders and/or effect modifiers of the main association between treatment (surgery vs surgery+adjuvant therapy) and vital status (dead vs alive). Results. We analyzed age groups, stage at diagnosis (i.e. localized vs. regionalized), ethnicity and histology. Age groups and stage were effect modifiers, while the latter two were not found to be neither effect modifiers nor confounders. Patients who had surgery alone in localized stage, age 37-50, were 7.39 times more likely to die than those who underwent surgery+adjuvant therapy. When comparing the surgery alone versus surgery+adjuvant we found that patients who underwent surgery alone were 4.6 times more likely to die than patients that underwent surgery + adjuvant therapy. Conclusion. According to age of patient and the stage of the disease, patients younger than 36 years old have higher chances of dying if they undergo surgery alone than older patients; patients between 37-50 years old have higher chances of dying from surgery alone in the localized stage than in regionalized stage. Surgery alone is not indicated in the localized melanoma of the skin. Grants and Acknowledgement. This study was funded in part through the HPD Research Grant for Florida Cancer Registry Analysis, 2004-2007. The views expressed herein are solely those of the authors and do not necessarily reflect those of FCDS, the contractor of FL-DOH.

This document is currently not available here.

Share

COinS
 
Apr 25th, 12:00 AM Apr 25th, 12:00 AM

Adequacy of Treatments in the Case of the Melanoma of the Skin Controlling for Age and Stage

Signature Grand, Davie, Florida, USA

Objectives. Is surgery+adjuvant therapy a better treatment than surgery alone in the case of localized melanoma of the skin? Background. Melanoma of the skin is a cancer that begins in the melanocytes. The cells keep making melanin which often gives the tumor brown or black color. People with darker skin may have lower incidence of the disease, but may develop melanoma as well as people with white skin. Methods. We studied 18,550 individuals diagnosed for the first time with melanoma of the skin in the State of Florida from January 1st 1994 to December 31st 2002. The study design was a cross-sectional, with incident cases over the study period. We used the relative risk as a measure of association. The stratified Mantel-Haenszel methodology was used to assess confounders and/or effect modifiers of the main association between treatment (surgery vs surgery+adjuvant therapy) and vital status (dead vs alive). Results. We analyzed age groups, stage at diagnosis (i.e. localized vs. regionalized), ethnicity and histology. Age groups and stage were effect modifiers, while the latter two were not found to be neither effect modifiers nor confounders. Patients who had surgery alone in localized stage, age 37-50, were 7.39 times more likely to die than those who underwent surgery+adjuvant therapy. When comparing the surgery alone versus surgery+adjuvant we found that patients who underwent surgery alone were 4.6 times more likely to die than patients that underwent surgery + adjuvant therapy. Conclusion. According to age of patient and the stage of the disease, patients younger than 36 years old have higher chances of dying if they undergo surgery alone than older patients; patients between 37-50 years old have higher chances of dying from surgery alone in the localized stage than in regionalized stage. Surgery alone is not indicated in the localized melanoma of the skin. Grants and Acknowledgement. This study was funded in part through the HPD Research Grant for Florida Cancer Registry Analysis, 2004-2007. The views expressed herein are solely those of the authors and do not necessarily reflect those of FCDS, the contractor of FL-DOH.